ASTCT is now accepting abstracts for the 2025 ASTCT Gene Therapy Summit.
Submit an Abstract
Call for Abstracts Timeline
- Friday, July 18: Call for abstracts opens
- Sunday, August 10: Call for abstracts closes
- Mid-August: Decisions for abstracts sent
Abstract Submission Criteria
Abstracts will be scored based on the following criteria; however, our Organizing Committee is also open to submissions that focus on practical tips, education, implementation strategies, and quality projects in the field of gene therapy:
- Importance and Relevance: Is a clear rationale for the work provided? Does the study address an important question? Do its findings have the potential to advance the field of gene therapy?
- Originality and Innovation: Is the work novel? Does it present new findings and/or address a problem using an original or improved approach?
- Quality of Methods and Writing: Are methods well described and valid to answer the question? Is the abstract clear and well written? Is the abstract within the 300-word limit?
Please note that the abstract submission form does not have a tracker for word count. We recommend that you prepare your abstract submission in a Word document to confirm that you stay within the 300-word limit.
All accepted abstracts will be required to attend and present their posters at the Summit during the reception on Wednesday, September 10.
Responsibility of Abstract Authors
The Presenting Author is responsible for the following:
- Ensuring that all authors have read the abstract and agreed to be co-authors.
- Notifying all co-authors of any additions, deletions, and changes to the program, as may be communicated by the 2025 ASTCT Gene Therapy Summit.
- Obtaining all of the conflict-of-interest disclosure information from co-authors.
- Making certain that abstracts are complete (tables included and labeled) and written in clear, concise and grammatically correct English, so that reviewers are able to focus solely on the scientific merits of the submission. For authors with any questions regarding the clarity, grammar or spelling of their abstract, we encourage identifying and using an independent reviewer to edit the abstract prior to submission.
Please contact Haedyn Smith (hsmith@astct.org) with any questions regarding your submission.
When you begin your submission, you will be asked to "Name this Entry", please use this section to include the high-level topic/area/theme that your submission will address.